Дизартрична симптоматика, маркери и съпътстващи дефицити в синдрома на Паркинсон

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Дизартрията е състояние, което често съпътства неврологичните заболявания от централен и периферен тип (вродени и придобити). В синдрома на Паркинсон тя е сериозно предизвикателство за всеки специалист, извършващ терапевтична или изследователска дейност с подобен род патология. Сама по себе си дизартрията засяга и разстройва всички нива на органите и структурите, отговорни за говорната продукция. При редица неврологични заболявания адекватното лечение обикновено води до подобрение или ограничаване на прогреса на дизартричната симптоматика. В синдрома на Паркинсон терапията ѝ е свързана с редица трудности поради факта, че в основата на болестта стои дегенеративен разпад от централен тип, който с времето прогресира и влошава наличната симптоматика. Причината е липса на утвърдено лечение, заменено от поддържаща терапия, която да повиши качеството на живот на болните. Материалът описва характерните за това заболяване дисфункции във всички компоненти на говора: дишане, фонация, артикулация и прозодика. Проведеният теоретичен анализ на литературата има за цел да очертае различния и комплексен характер на дизартрията при Паркинсонов синдром, допълнена в много от случаите с признаци на говорна апраксия и дисфагия. Библиография: Ackermann, H., & Ziegler, W. (1991). Articulatory deficits in Parkinsonian dysarthria: An acoustic analysis. Journal of Neurology, Neurosurgery & Psychiatry, 54(12), 1093–1098. Alm, P. (2004). Stuttering and the basal ganglia circuits: a critical review of possible relations. Journal of Communication Disorders, 37, 325–369. Arman, A., Lorente-Ramos, R. M., García, G., & Collazo Lorduy, C. (2019). Videofluoroscopic evaluation of normal and impaired oropharyngeal swallowing. Radio Graphics, 39(1), 78–79. https://doi.org/10.1148/rg.2019180070 Barnish, M. S., Horton, S. M. C., Butterfint, Z. R., Clark, A. B., Atkinson, R. A., & Deane, K. H. O. (2017). Speech and communication in Parkinson's disease: a cross-sectional exploratory study in the UK. BMJ Open, 7(5), e014642. Bejjani, B. P., Gervais, D., Arnulf, I., Papadopoulos, S., Demeret, S., Bonnet, A. M., & et al. (2000). Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation. Journal of Neurology, Neurosurgery & Psychiatry, 68(5), 595–600. doi: 10.1136/jnnp.68.5.595 Brabenec, L., Mekyska, J., Galaz, Z., & Rektorova, I. (2017). Speech disorders in Parkinson’s disease: early diagnostics and effects of medication and brain stimulation. Journal of Neural Transmission, 124, 303–334. doi: 10.1007/s00702-017-1676-0 Branco, L. L., Trentin, S., Augustin Schwanke, C. H., Gomes, I., & Loureiro, F. (2019). The swallowing clinical assessment score in Parkinson’s disease (SCAS-PD) is a valid and low-cost tool for evaluation of Dysphagia: a gold-standard comparison study. Journal of Aging Research, 1–7. https://doi.org/10.1155/2019/7984635 Bunton, K. (2005). Patterns of lung volume use during an extemporaneous speech task in persons with Parkinson disease. Journal of Communication Disorders, 38, 331–348. Cardoso, R., Guimarães, I., Santos, H., & et al. (2016). Frenchay Dysarthria Assessment (FDA-2) in Parkinson’s disease: cross-cultural adaptation and psychometric properties of the European Portuguese version. Journal of Neurology, 264(1), 2131. https://doi.org/10.1007/s00415-016-8298-6 Chen, Y., Zhu, G., Liu, D., Liu, Y., Yuan, T., Zhang, X., & et al. (2020). Brain morphological changes in hypokinetic dysarthria of Parkinson’s disease and use of machine learning to predict severity. CNS Neuroscience & Therapeutics, 26, 711–719. doi: 10.1111/cns.13304 Clifford, T., & Finnerty, J. (1995). The dental awareness and needs of a Parkinson’s disease population. Gerodontology, 12(12), 99–103. Critchley, E. M. (1981). Speech disorders of Parkinsonism: A review. Journal of Neurology, Neurosurgery & Psychiatry, 44(9), 751–758. https://doi.org/10.1136/jnnp.44.9.751 Darley, F. L., Aronson, A. E., & Brown, J. R. (1969). Differential diagnostic patterns of dysarthria. Journal of Speech and Hearing Research, 12(2), 246–269. Dashtipour, K., Tafreshi, A., Lee, J., & Crawley, B. (2018). Speech disorders in Parkinson’s disease: pathophysiology, medical management and surgical approaches. Neurodegenerative Disease Management, 8, 337–348. doi: 10.2217/nmt-2018-0021 De Nil, L. F., Rochon, E., & Jokel, R. (2009). Adult Onset Neurogenic Suttering. In: M. R. McNeil (Ed.), Clinical Management of Sensoriomotor Speech Disorders (2nd ed., pp. 235–248). Thieme. Dromey, C. (2003). Spectral measures and perceptual ratings of hypokinetic dysarthria. Journal of Medical Speech-Language Pathology, 11, 85–94. Duffy, J. (2005). Motor Speech Disorders: Substrates, Differential Diagnosis, and Management. Elsevier Mosby. Duffy, J. R. (2013). Chapter 1. Motor speech disorders-E-book: substrates, differential diagnosis, and management (pp. 3–94). Elsevier Health Sciences. Duffy, J. R. (2019). Motor Speech Disorders E-Book: Substrates, Differential Diagnosis, and Management. Elsevier Health Sciences. Duffy, J. R. (2020). Motor Speech Disorders. Substrates, Differential Diagnosis, and Management (4th ed.). Elsevier. Ebihara, E., Saito, H., Kanda, A., & et al. (2003). Impaired efficacy of cough in patients with Parkinson’s disease. Chest, 124(3), 1009–1015. Forrest, K., Weismer, G., & Turner, G. S. (1989). Kinematic, acoustic, and perceptual analysis of connected speech produced by parkinsonian and normal geriatric adults. Journal of the Acoustical Society of America, 85(6), 2608–2622. Gandhi, P., Mancopes, R., Sutton, D., Plowman, E. K., & Steele, C. M. (2021). The frequency of atypical and extreme values for pharyngeal phase swallowing measures in mild Parkinson’s disease compared to healthy aging. Journal of Speech, Language, and Hearing Research, 64(8), 3032-3050. https://doi.org/10.1044/2021_jslhr-21-00084 Gentilhomme, A., Tir, M., & Renard, A. (2020). Dysarthrie dans la maladie de Parkinson. Quelle est la sévérité de la dysarthrie au moment de la première évaluation en orthophonie pour prise en soin? Neurologies, 23, 213. Goetz, C. G., & et al. (2008). Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Movement Disorders, 23(15), 2129–2170. Grammatikopoulou, A., Grammalidis, N., Bostantjopoulou, S., & Katsarou, Z. (2019). Detecting hypomimia symptoms by selfie photo analysis: for early Parkinson disease detection. In: Proceedings of the 12th ACM International Conference on PErvasive Technologies Related to Assistive Environments (pp. 517–522). Guedes, L. U., Rodrigues, J. M., Fernandes, A. A., Cardoso, F. E., & Parreira, V. F. (2012). Respiratory changes in Parkinson’s disease may be unrelated to dopaminergic dysfunction. Arquivos de Neuro-Psiquiatria, 70(11), 847–851. Hammer, M. J. (2013). Aerodynamic assessment of phonatory onset in Parkinson’s disease: evidence of decreased scaling of laryngeal and respiratory control. Journal of Parkinson's Disease, 3(2), 173–179. https://doi.org/10.3233/JPD-130180 Hartelius, L. (2015). Dysartri - Bedömning och Intervention: vid Förvärvade Neurologiska Talstörningar hos Vuxna. Studentlitteratur. Hirsch, L., Jette, N., Frolkis, A., Steeves, T., & Pringsheim, T. (2016). The incidence of Parkinson’s disease: a systematic review and meta-analysis. Neuroepidemiology, 46, 292–300. Ho, A. K., Bradshaw, J. L., & Iansek, R. (2000). Volume perception in Parkinsonian speech. Movement Disorders, 15, 1125–1131. doi: 10.1002/1531-8257(200011)15:6